{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:31:28Z","timestamp":1769045488739,"version":"3.49.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["402170461"],"award-info":[{"award-number":["402170461"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["402170461"],"award-info":[{"award-number":["402170461"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["324164820"],"award-info":[{"award-number":["324164820"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["324164820"],"award-info":[{"award-number":["324164820"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["421888313"],"award-info":[{"award-number":["421888313"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["437718741"],"award-info":[{"award-number":["437718741"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Rationale<\/jats:title>\n                <jats:p>Alcohol use disorder is a common and devastating mental illness for which satisfactory treatments are still lacking. Nalmefene, as an opioid receptor modulator, could pharmacologically support the reduction of drinking by reducing the (anticipated) rewarding effects of alcohol and expanding the range of treatment options. It has been hypothesized that nalmefene acts via an indirect modulation of the mesolimbic reward system. So far, only a few imaging findings on the neuronal response to nalmefene are available.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>We tested the effect of a single dose of 18 mg nalmefene on neuronal cue-reactivity in the ventral and dorsal striatum and subjective craving.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Eighteen non-treatment-seeking participants with alcohol use disorder (67% male, <jats:italic>M<\/jats:italic> = 50.3 \u00b1 13.9 years) with a current high-risk drinking level (<jats:italic>M<\/jats:italic> = 76.9 \u00b1 52 g of pure alcohol per day) were investigated using a cue-reactivity task during functional magnetic resonance imaging (fMRI) in a double-blind, placebo-controlled, cross-over study\/design. In addition, self-reported craving was assessed before and after exposure to alcohol cues.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>An a priori defined region of interest (ROI) analysis of fMRI data from 15 participants revealed that nalmefene reduced alcohol cue-reactivity in the ventral, but not the dorsal striatum. Additionally, the subjective craving was significantly reduced after the cue-reactivity task under nalmefene compared to placebo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In the present study, reduced craving and cue-reactivity to alcohol stimuli in the ventral striatum by nalmefene indicates a potential anti-craving effect of this drug via attenuation of neural alcohol cue-reactivity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00213-021-05842-7","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T17:02:56Z","timestamp":1618246976000},"page":"2179-2189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder"],"prefix":"10.1007","volume":"238","author":[{"given":"Damian","family":"Karl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Malte","family":"Bumb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Bach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Dinter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Koopmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derik","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Kiefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-672X","authenticated-orcid":false,"given":"Sabine","family":"Vollst\u00e4dt-Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"5842_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0740-5472(01)00210-0","volume":"22","author":"JA Ambrogne","year":"2002","unstructured":"Ambrogne JA (2002) Reduced-risk drinking as a treatment goal: what clinicians need to know. J Subst Abus Treat 22:45\u201353. https:\/\/doi.org\/10.1016\/s0740-5472(01)00210-0","journal-title":"J Subst Abus Treat"},{"key":"5842_CR2","volume-title":"Inventory of drinking situations (IDS): user's guide","author":"H Annis","year":"1987","unstructured":"Annis H, Graham JM, Davis CS (1987) Inventory of drinking situations (IDS): user's guide. Addiction Research Foundation, Toronto"},{"key":"5842_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1056\/NEJMct0801733","volume":"359","author":"RF Anton","year":"2008","unstructured":"Anton RF (2008) Naltrexone for the management of alcohol dependence. N Engl J Med 359:715\u2013721. https:\/\/doi.org\/10.1056\/NEJMct0801733","journal-title":"N Engl J Med"},{"key":"5842_CR4","unstructured":"Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2001) AUDIT. The alcohol use disorders identification test. Guidelines for Use in Primary Care, 2 edn. World Health Organization, Geneva, Switzerland"},{"key":"5842_CR5","doi-asserted-by":"publisher","first-page":"e12717","DOI":"10.1111\/adb.12717","volume":"25","author":"P Bach","year":"2020","unstructured":"Bach P, Weil G, Pompili E, Hoffmann S, Hermann D, Vollst\u00e4dt-Klein S, Mann K, Perez-Ramirez U, Moratal D, Canals S, Dursun SM, Greenshaw AJ, Kirsch P, Kiefer F, Sommer WH (2020) Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone. Addict Biol 25:e12717. https:\/\/doi.org\/10.1111\/adb.12717","journal-title":"Addict Biol"},{"key":"5842_CR6","doi-asserted-by":"publisher","DOI":"10.4324\/9781410612625","volume-title":"Understanding statistics in the behavioral sciences","author":"R Bakeman","year":"2005","unstructured":"Bakeman R, Robinson BF (2005) Understanding statistics in the behavioral sciences. Psychology Press, New York. https:\/\/doi.org\/10.4324\/9781410612625"},{"key":"5842_CR7","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/sj.npp.1300811","volume":"30","author":"G Bart","year":"2005","unstructured":"Bart G, Schluger JH, Borg L, Ho A, Bidlack JM, Kreek MJ (2005) Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity? Neuropsychopharmacology 30:2254\u20132262. https:\/\/doi.org\/10.1038\/sj.npp.1300811","journal-title":"Neuropsychopharmacology"},{"key":"5842_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3238\/arztebl.2016.0301","volume":"113","author":"A Batra","year":"2016","unstructured":"Batra A, M\u00fcller CA, Mann K, Heinz A (2016) Alcohol dependence and harmful use of alcohol. Dtsch Arztebl Int 113:301\u2013310. https:\/\/doi.org\/10.3238\/arztebl.2016.0301","journal-title":"Dtsch Arztebl Int"},{"key":"5842_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561\u2013571. https:\/\/doi.org\/10.1001\/archpsyc.1961.01710120031004","journal-title":"Arch Gen Psychiatry"},{"key":"5842_CR10","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1530-0277.1995.tb01554.x","volume":"19","author":"MJ Bohn","year":"1995","unstructured":"Bohn MJ, Krahn DD, Staehler BA (1995) Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19:600\u2013606. https:\/\/doi.org\/10.1111\/j.1530-0277.1995.tb01554.x","journal-title":"Alcohol Clin Exp Res"},{"key":"5842_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s007020170038","volume":"108","author":"DF Braus","year":"2001","unstructured":"Braus DF et al (2001) Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholics. J Neural Transm 108:887\u2013894. https:\/\/doi.org\/10.1007\/s007020170038","journal-title":"J Neural Transm"},{"key":"5842_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000494692","volume":"24","author":"P Castera","year":"2018","unstructured":"Castera P et al (2018) Nalmefene, given as needed, in the routine treatment of patients with alcohol dependence: an interventional, open-label study in primary care. Eur Addict Res 24:293\u2013303. https:\/\/doi.org\/10.1159\/000494692","journal-title":"Eur Addict Res"},{"key":"5842_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/adb.12314","volume":"21","author":"KE Courtney","year":"2016","unstructured":"Courtney KE, Schacht JP, Hutchison K, Roche DJO, Ray LA (2016) Neural substrates of cue reactivity: association with treatment outcomes and relapse. Addict Biol 21:3\u201322. https:\/\/doi.org\/10.1111\/adb.12314","journal-title":"Addict Biol"},{"key":"5842_CR14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.biopsych.2019.05.021","volume":"86","author":"B de Laat","year":"2019","unstructured":"de Laat B et al (2019) The kappa opioid receptor is associated with naltrexone-induced reduction of drinking and craving. Biol Psychiatry 86:864\u2013871. https:\/\/doi.org\/10.1016\/j.biopsych.2019.05.021","journal-title":"Biol Psychiatry"},{"key":"5842_CR15","first-page":"179","volume":"23","author":"DJ Drobes","year":"1999","unstructured":"Drobes DJ, Thomas SE (1999) Assessing craving for alcohol. Alcohol Res Health 23:179\u2013186","journal-title":"Alcohol Res Health"},{"key":"5842_CR16","unstructured":"Online document. European Medicines Agency [EMA] (2013) EPAR summary for the public. Selincro. Nalmefen. EMA\/826403\/2012, EMEA\/H\/C\/002583."},{"key":"5842_CR17","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nn1579","volume":"8","author":"BJ Everitt","year":"2005","unstructured":"Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481\u20131489. https:\/\/doi.org\/10.1038\/nn1579","journal-title":"Nat Neurosci"},{"key":"5842_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-psych-122414-033457","volume":"67","author":"BJ Everitt","year":"2016","unstructured":"Everitt BJ, Robbins TW (2016) Drug addiction: updating actions to habits to compulsions ten years on. Annu Rev Psychol 67:23\u201350. https:\/\/doi.org\/10.1146\/annurev-psych-122414-033457","journal-title":"Annu Rev Psychol"},{"key":"5842_CR19","first-page":"304","volume":"26","author":"C Gianoulakis","year":"2001","unstructured":"Gianoulakis C (2001) Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J Psychiatry Neurosci 26:304\u2013318","journal-title":"J Psychiatry Neurosci"},{"key":"5842_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00213-004-1828-4","volume":"175","author":"SM Gr\u00fcsser","year":"2004","unstructured":"Gr\u00fcsser SM et al (2004) Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology 175:296\u2013302. https:\/\/doi.org\/10.1007\/s00213-004-1828-4","journal-title":"Psychopharmacology"},{"key":"5842_CR21","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.euroneuro.2013.02.006","volume":"23","author":"A Gual","year":"2013","unstructured":"Gual A, He Y, Torup L, van den Brink W, Mann K (2013) A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol 23:1432\u20131442. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.02.006","journal-title":"Eur Neuropsychopharmacol"},{"key":"5842_CR22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119\u20131127. https:\/\/doi.org\/10.1111\/j.1360-0443.1991.tb01879.x","journal-title":"Br J Addict"},{"key":"5842_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neubiorev.2009.11.018","volume":"35","author":"M Heilig","year":"2010","unstructured":"Heilig M et al (2010) Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev 35:334\u2013344. https:\/\/doi.org\/10.1016\/j.neubiorev.2009.11.018","journal-title":"Neurosci Biobehav Rev"},{"key":"5842_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1369-1600.2008.00136.x","volume":"14","author":"A Heinz","year":"2009","unstructured":"Heinz A, Beck A, Gr\u00fcsser SM, Grace AA, Wrase J (2009) Identifying the neural circuitry of alcohol craving and relapse vulnerability. Addict Biol 14:108\u2013118. https:\/\/doi.org\/10.1111\/j.1369-1600.2008.00136.x","journal-title":"Addict Biol"},{"key":"5842_CR25","doi-asserted-by":"publisher","first-page":"e12866","DOI":"10.1111\/adb.12866","volume":"25","author":"A Heinz","year":"2020","unstructured":"Heinz A et al (2020) Addiction research consortium: losing and regaining control over drug intake (ReCoDe)\u2014from trajectories to mechanisms and interventions. Addict Biol 25:e12866. https:\/\/doi.org\/10.1111\/adb.12866","journal-title":"Addict Biol"},{"key":"5842_CR26","doi-asserted-by":"publisher","unstructured":"Hendershot CS, Wardell JD, Samokhvalov AV, Rehm J (2016) Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies Addiction biology: Advanced online publication doi:https:\/\/doi.org\/10.1111\/adb.12425","DOI":"10.1111\/adb.12425"},{"key":"5842_CR27","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1038\/sj.npp.1300790","volume":"30","author":"K Ingman","year":"2005","unstructured":"Ingman K et al (2005) Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing. Neuropsychopharmacology 30:2245\u20132253. https:\/\/doi.org\/10.1038\/sj.npp.1300790","journal-title":"Neuropsychopharmacology"},{"key":"5842_CR28","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2014.3628","volume":"311","author":"DE Jonas","year":"2014","unstructured":"Jonas DE et al (2014) Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA 311:1889\u20131900. https:\/\/doi.org\/10.1001\/jama.2014.3628","journal-title":"JAMA"},{"key":"5842_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neuroimage.2013.03.055","volume":"78","author":"SE Lukas","year":"2013","unstructured":"Lukas SE et al (2013) Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study. NeuroImage 78:176\u2013185. https:\/\/doi.org\/10.1016\/j.neuroimage.2013.03.055","journal-title":"NeuroImage"},{"key":"5842_CR30","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/j.1530-0277.2006.00159.x","volume":"30","author":"J MacKillop","year":"2006","unstructured":"MacKillop J (2006) Factor structure of the alcohol urge questionnaire under neutral conditions and during a cue-elicited urge state. Alcohol Clin Exp Res 30:1315\u20131321. https:\/\/doi.org\/10.1111\/j.1530-0277.2006.00159.x","journal-title":"Alcohol Clin Exp Res"},{"key":"5842_CR31","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.biopsych.2012.10.020","volume":"73","author":"K Mann","year":"2013","unstructured":"Mann K, Bladstr\u00f6m A, Torup L, Gual A, van den Brink W (2013) Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry 73:706\u2013713. https:\/\/doi.org\/10.1016\/j.biopsych.2012.10.020","journal-title":"Biol Psychiatry"},{"key":"5842_CR32","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1111\/acer.12546","volume":"38","author":"K Mann","year":"2014","unstructured":"Mann K et al (2014) Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging. Alcohol Clin Exp Res 38:2754\u20132762. https:\/\/doi.org\/10.1111\/acer.12546","journal-title":"Alcohol Clin Exp Res"},{"key":"5842_CR33","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.euroneuro.2016.10.008","volume":"26","author":"K Mann","year":"2016","unstructured":"Mann K, Torup L, S\u00f8rensen P, Gual A, Swift R, Walker B, van den Brink W (2016) Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy. Eur Neuropsychopharmacol 26:1941\u20131949. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.10.008","journal-title":"Eur Neuropsychopharmacol"},{"key":"5842_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cpr.2017.07.006","volume":"57","author":"AI Mellentin","year":"2017","unstructured":"Mellentin AI, Sk\u00f8t L, Nielsen B, Schippers GM, Nielsen AS, Stenager E, Juhl C (2017) Cue exposure therapy for the treatment of alcohol use disorders: a meta-analytic review. Clin Psychol Rev 57:195\u2013207. https:\/\/doi.org\/10.1016\/j.cpr.2017.07.006","journal-title":"Clin Psychol Rev"},{"key":"5842_CR35","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/pcn.12914","volume":"73","author":"H Miyata","year":"2019","unstructured":"Miyata H et al (2019) Nalmefene in alcohol-dependent patients with a high drinking risk: randomized controlled trial. Psychiatry Clin Neurosci 73:697\u2013706. https:\/\/doi.org\/10.1111\/pcn.12914","journal-title":"Psychiatry Clin Neurosci"},{"key":"5842_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00213-008-1249-x","volume":"201","author":"RF Mucha","year":"2008","unstructured":"Mucha RF, Pauli P, Weber M, Winkler M (2008) Smoking stimuli from the terminal phase of cigarette consumption may not be cues for smoking in healthy smokers. Psychopharmacology 201:81\u201395. https:\/\/doi.org\/10.1007\/s00213-008-1249-x","journal-title":"Psychopharmacology"},{"key":"5842_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/archpsyc.65.4.466","volume":"65","author":"H Myrick","year":"2008","unstructured":"Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K (2008) Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry 65:466\u2013475. https:\/\/doi.org\/10.1001\/archpsyc.65.4.466","journal-title":"Arch Gen Psychiatry"},{"key":"5842_CR38","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","volume":"49","author":"SS O'Malley","year":"1992","unstructured":"O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49:881\u2013887. https:\/\/doi.org\/10.1001\/archpsyc.1992.01820110045007","journal-title":"Arch Gen Psychiatry"},{"key":"5842_CR39","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/add.14234","volume":"113","author":"A Peacock","year":"2018","unstructured":"Peacock A et al (2018) Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction 113:1905\u20131926. https:\/\/doi.org\/10.1111\/add.14234","journal-title":"Addiction"},{"key":"5842_CR40","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.biopsych.2016.12.029","volume":"81","author":"DR Quelch","year":"2017","unstructured":"Quelch DR et al (2017) Nalmefene reduces reward anticipation in alcohol dependence\u2014an experimental fMRI study. Biol Psychiatry 81:941\u2013948. https:\/\/doi.org\/10.1016\/j.biopsych.2016.12.029","journal-title":"Biol Psychiatry"},{"key":"5842_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1360-0443.2005.00960.x","volume":"100","author":"A Raabe","year":"2005","unstructured":"Raabe A, Gr\u00fcsser SM, Wessa M, Podschus J, Flor H (2005) The assessment of craving: psychometric properties, factor structure and a revised version of the Alcohol Craving Questionnaire (ACQ). Addiction 100:227\u2013234. https:\/\/doi.org\/10.1111\/j.1360-0443.2005.00960.x","journal-title":"Addiction"},{"key":"5842_CR42","doi-asserted-by":"crossref","unstructured":"Rehm J, Shield KD, Rehm MX, Gmel G, Frick U (2012) Alcohol consumption, alcohol dependence and attributable burden of disease in Europe: potential gains from effective interventions for alcohol dependence. Centre for Addiction and Mental Health, Toronto, Canada","DOI":"10.1037\/e506502014-001"},{"key":"5842_CR43","doi-asserted-by":"publisher","unstructured":"Rehm J, Allamani A., Elekes Z., Jakubczyk A., Manthey J., Probst C., Struzzo P., Della Vedova R., Gual A., Wojnar M. (2015) Alcohol dependence and treatment utilization in Europe\u2014a representative cross-sectional study in primary care 16 doi:https:\/\/doi.org\/10.1186\/s12875-015-0308-8","DOI":"10.1186\/s12875-015-0308-8"},{"key":"5842_CR44","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1530-0277.2002.tb02534.x","volume":"26","author":"DF Reinert","year":"2002","unstructured":"Reinert DF, Allen JP (2002) The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol Clin Exp Res 26:272\u2013279. https:\/\/doi.org\/10.1111\/j.1530-0277.2002.tb02534.x","journal-title":"Alcohol Clin Exp Res"},{"key":"5842_CR45","doi-asserted-by":"publisher","unstructured":"R\u00f6sner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (2010) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD001867.pub3","DOI":"10.1002\/14651858.CD001867.pub3"},{"key":"5842_CR46","doi-asserted-by":"publisher","first-page":"506","DOI":"10.15288\/jsa.1990.51.506","volume":"51","author":"HE Ross","year":"1990","unstructured":"Ross HE, Gavin DR, Skinner HA (1990) Diagnostic validity of the MAST and the alcohol dependence scale in the assessment of DSM-III alcohol disorders. J Stud Alcohol 51:506\u2013513. https:\/\/doi.org\/10.15288\/jsa.1990.51.506","journal-title":"J Stud Alcohol"},{"key":"5842_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1369-1600.2012.00464.x","volume":"18","author":"JP Schacht","year":"2013","unstructured":"Schacht JP, Anton RF, Myrick H (2013) Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol 18:121\u2013133. https:\/\/doi.org\/10.1111\/j.1369-1600.2012.00464.x","journal-title":"Addict Biol"},{"key":"5842_CR48","doi-asserted-by":"publisher","unstructured":"Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF (2017) Predictors of naltrexone response in a randomized trial: reward-related brain activation, OPRM1 genotype, and smoking status Neuropsychopharmacol online publication doi:https:\/\/doi.org\/10.1038\/npp.2017.74","DOI":"10.1038\/npp.2017.74"},{"key":"5842_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000081417","volume":"11","author":"A Scheurich","year":"2005","unstructured":"Scheurich A, M\u00fcller MJ, Anghelescu I, L\u00f6rch B, Dreher M, Hautzinger M, Szegedi A (2005) Reliability and validity of the form 90 interview. Eur Addict Res 11:50\u201356. https:\/\/doi.org\/10.1159\/000081417","journal-title":"Eur Addict Res"},{"key":"5842_CR50","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1126\/science.275.5306.1593","volume":"275","author":"W Schultz","year":"1997","unstructured":"Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction and reward. Science 275:1593\u20131599. https:\/\/doi.org\/10.1126\/science.275.5306.1593","journal-title":"Science"},{"key":"5842_CR51","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1038\/tp.2013.107","volume":"3","author":"Z Sjoerds","year":"2013","unstructured":"Sjoerds Z, de Wit S, van den Brink W, Robbins TW, Beekman ATF, Penninx BWJH, Veltman DJ (2013) Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients. Transl Psychiatry 3:e337. https:\/\/doi.org\/10.1038\/tp.2013.107","journal-title":"Transl Psychiatry"},{"key":"5842_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1037\/0021-843x.91.3.199","volume":"91","author":"HA Skinner","year":"1982","unstructured":"Skinner HA, Allen BA (1982) Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91:199\u2013209. https:\/\/doi.org\/10.1037\/0021-843x.91.3.199","journal-title":"J Abnorm Psychol"},{"key":"5842_CR53","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/09652149541392","volume":"90","author":"MB Sobell","year":"1995","unstructured":"Sobell MB, Sobell LC (1995) Controlled drinking after 25 years: how important was the great debate? Addiction 90:1149\u20131153. https:\/\/doi.org\/10.1080\/09652149541392","journal-title":"Addiction"},{"key":"5842_CR54","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1080\/14656566.2017.1349098","volume":"18","author":"M Soyka","year":"2017","unstructured":"Soyka M, M\u00fcller CA (2017) Pharmacotherapy of alcoholism\u2014an update on approved and off-label medications. Expert Opin Pharmacother 18:1187\u20131199. https:\/\/doi.org\/10.1080\/14656566.2017.1349098","journal-title":"Expert Opin Pharmacother"},{"key":"5842_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0166-2236(99)01447-2","volume":"22","author":"R Spanagel","year":"1999","unstructured":"Spanagel R, Weiss F (1999) The dopamine hypothesis of reward: past and current status. Trends Neurosci 22:521\u2013527. https:\/\/doi.org\/10.1016\/S0166-2236(99)01447-2","journal-title":"Trends Neurosci"},{"key":"5842_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0165-6147(97)89800-8","volume":"18","author":"R Spanagel","year":"1997","unstructured":"Spanagel R, Zieglgansberger W (1997) Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18:54\u201359. https:\/\/doi.org\/10.1016\/S0165-6147(97)89800-8","journal-title":"Trends Pharmacol Sci"},{"key":"5842_CR57","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","volume":"84","author":"JT Sullivan","year":"1989","unstructured":"Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84:1353\u20131357. https:\/\/doi.org\/10.1111\/j.1360-0443.1989.tb00737.x","journal-title":"Br J Addict"},{"key":"5842_CR58","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.biopsych.2013.03.002","volume":"73","author":"RM Swift","year":"2013","unstructured":"Swift RM (2013) Naltrexone and nalmefene: any meaningful difference? Biol Psychiatry 73:700\u2013701. https:\/\/doi.org\/10.1016\/j.biopsych.2013.03.002","journal-title":"Biol Psychiatry"},{"key":"5842_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/09652140050111717","volume":"95","author":"ST Tiffany","year":"2000","unstructured":"Tiffany ST, Conklin CA (2000) A cognitive processing model of alcohol craving and compulsive alcohol use. Addiction 95:145\u2013153. https:\/\/doi.org\/10.1080\/09652140050111717","journal-title":"Addiction"},{"key":"5842_CR60","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/alcalc\/agt061","volume":"48","author":"W van den Brink","year":"2013","unstructured":"van den Brink W, Aubin HJ, Bladstrom A, Torup L, Gual A, Mann K (2013) Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies Alcohol. Alcohol 48:570\u2013578. https:\/\/doi.org\/10.1093\/alcalc\/agt061","journal-title":"Alcohol"},{"key":"5842_CR61","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1111\/j.1360-0443.2010.03022.x","volume":"105","author":"S Vollst\u00e4dt-Klein","year":"2010","unstructured":"Vollst\u00e4dt-Klein S et al (2010) Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum. Addiction 105:1741\u20131749. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03022.x","journal-title":"Addiction"},{"key":"5842_CR62","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.euroneuro.2019.10.014","volume":"29","author":"S Vollst\u00e4dt-Klein","year":"2019","unstructured":"Vollst\u00e4dt-Klein S et al (2019) The effects of nalmefene on emotion processing in alcohol use disorder\u2014a randomized, controlled fMRI study. Eur Neuropsychopharmacol 29:1442\u20131452. https:\/\/doi.org\/10.1016\/j.euroneuro.2019.10.014","journal-title":"Eur Neuropsychopharmacol"},{"key":"5842_CR63","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"JR Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876\u2013880. https:\/\/doi.org\/10.1001\/archpsyc.1992.01820110040006","journal-title":"Arch Gen Psychiatry"},{"key":"5842_CR64","doi-asserted-by":"publisher","unstructured":"Wiers CE, Heinz A (2015) Neurobiology of alcohol craving and relapse prediction. John Wiley & Sons, West Sussex, Great Britain. doi:https:\/\/doi.org\/10.1002\/9781118472415.ch10","DOI":"10.1002\/9781118472415.ch10"},{"key":"5842_CR65","unstructured":"Wittchen H-U, Wunderlich U, Gruschwitz S, Zaudig M (1997) SKID-I. Strukturiertes Klinisches Interview f\u00fcr DSM-IV. Achse I: Psychische St\u00f6rungen. Interviewheft und Beurteilungsheft. Hogrefe, G\u00f6ttingen"},{"key":"5842_CR66","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.neuroimage.2006.11.043","volume":"35","author":"J Wrase","year":"2007","unstructured":"Wrase J et al (2007) Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. NeuroImage 35:787\u2013794. https:\/\/doi.org\/10.1016\/j.neuroimage.2006.11.043","journal-title":"NeuroImage"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05842-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T03:36:51Z","timestamp":1626838611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05842-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["5842"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05842-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]},"assertion":[{"value":"22 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study procedures were in accordance with the Declaration of Helsinki. The study was approved by the ethics committee of the University of Heidelberg (Ethics Commission II: 2014-607N-MA).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Outside the submitted work, Derik Hermann received honoraria for participating in advisory boards of the pharmaceutical companies Indivior, Camurus, and Servier. Falk Kiefer received honoraria as a consultant for Amomed, Desitin, Indivior, Lundbeck und Otsuka. We do not have further commercial or financial involvements that might present an appearance of a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}